ACTRN12613000071729招募中未知
An international, observational study of the choice of resucitation fluid used in children in intensive care.
Dr Marino Festa0 个研究点目标入组 2,100 人开始时间: 2013年1月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 2,100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- Years 至 16 Years（—）
- 性别
- All
入选标准
- •All newborns, infants or children aged 0 to 16 years (inclusive) in a participating intensive care unit at 12:00 midday on the study days.
排除标准
- •Age 17 years or more
研究者
相似试验
已完成
不适用
Observational study to determine the type of patient with cervical dystonia that responds best to botulinum toxin treatmentIdiopathic Cervical DystoniaNeurological - Other neurological disordersACTRN12609000800224Ipsen40
进行中（未招募）
1 期
A clinical study with many of countries and sites participating. This study wants to look into the relationship of the genotype IL28B in patients from all over the world which are suffering from an inflammation of the liver with hepatitis C virusEUCTR2011-001096-39-SKF.Hoffmann-La Roche Ltd.4,200
进行中（未招募）
不适用
A Randomized, open label, international study of subcutaneous recombinant interleukin-2 with and without concomitant antiretroviral therapy in patient with HIV-1 infectious and CD4+ cell count >300/mm3 - STALWARTHIV-1 patients with CD4 > 300MedDRA version: 14.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2005-001490-95-ITational Institute of Allergy and Infectious Diseases300
进行中（未招募）
1 期
A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 (rIL-2, Aldesleukin) with and without Concomitant Antiretroviral Therapy in Patients with HIV-1 Infection and CD4+ Cell Counts = 300/mm3: Study of Aldesleukin with and without Antiretroviral Therapy (ESPRIT 002: STALWART) - STALWARTHIV infectionEUCTR2005-001490-95-GBational Institute of Allergy and Infectious Diseases (NIAID)480
进行中（未招募）
1 期
A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 (rIL-2, Aldesleukin) with and without Concomitant Antiretroviral Therapy in Patients with HIV-1 Infection and CD4+ Cell Counts = 300/mm3: Study of Aldesleukin with and without Antiretroviral Therapy (ESPRIT 002: STALWART) - STALWARTEUCTR2005-001490-95-PTational Institute of Allergy and Infectious Diseases (NIAID)480